317 results
Page 5 of 16
8-K/A
EX-99.1
0kgr2nl
19 Sep 19
Special Purpose Combined Statements of Revenues and Direct Expenses
9:26pm
8-K/A
EX-99.2
nm0i7d8i9227 vpsa3od
19 Sep 19
Special Purpose Combined Statements of Revenues and Direct Expenses
9:26pm
D
7cxusxn1r70inte 2wa
26 Jul 19
$27M in equity / options / securities to be acquired, sold $14M, 1 investor
8:15pm
8-K
EX-10.2
2478j0qpzj7
19 Jul 19
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
5:03pm
8-K
EX-2.1
kg34fid
19 Jul 19
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
5:03pm
8-K
EX-10.1
wayb 8849ri2c
19 Jul 19
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
5:03pm
8-K
EX-1.1
y99k6wzk1j99nj7
28 Jan 19
Interpace Diagnostics Announces Proposed Public Offering of Common Stock
9:40pm
424B5
e6hq8l3 se
28 Jan 19
Prospectus supplement for primary offering
5:29pm
424B5
8h8untn88mv
24 Jan 19
Prospectus supplement for primary offering
9:51pm